Application 008085

Type
NDA
Sponsor
DAVA PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002METHOTREXATE SODIUMMETHOTREXATE SODIUMTABLET;ORALEQ 2.5MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
42254-110METHOTREXATEMETHOTREXATERebel Distributors CorpNDACurrent
50090-0294METHOTREXATEMETHOTREXATEA-S Medication SolutionsNDACurrent
50090-0294METHOTREXATEMETHOTREXATEA-S Medication SolutionsNDACurrent
66336-338METHOTREXATEMETHOTREXATEDispensing Solutions, Inc.NDACurrent
67253-320METHOTREXATEMETHOTREXATEPar PharmaceuticalNDACurrent
67253-320METHOTREXATEMETHOTREXATEPar Pharmaceutical, Inc.NDACurrent
70518-0223METHOTREXATEMETHOTREXATEREMEDYREPACK INC.NDACurrent
70518-0223METHOTREXATEMETHOTREXATEREMEDYREPACK INC.NDACurrent
70518-0223METHOTREXATEMETHOTREXATEREMEDYREPACK INC.NDACurrent
75840-111METHOTREXATE SODIUMMETHOTREXATE SODIUMGenPak Solutions LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
62824SUPPL2020-05-05
62817SUPPL2020-05-05
53061SUPPL2018-03-20
53042SUPPL2018-03-16
32958SUPPL2016-02-18
142SUPPL2016-02-01
141SUPPL2006-06-02
32957SUPPL2003-11-05
32956SUPPL2003-11-05
91SUPPL2003-11-05
89SUPPL2003-11-05
140SUPPL2002-02-20
90SUPPL2002-02-20